PE20090433A1 - Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion - Google Patents
Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacionInfo
- Publication number
- PE20090433A1 PE20090433A1 PE2009000199A PE2009000199A PE20090433A1 PE 20090433 A1 PE20090433 A1 PE 20090433A1 PE 2009000199 A PE2009000199 A PE 2009000199A PE 2009000199 A PE2009000199 A PE 2009000199A PE 20090433 A1 PE20090433 A1 PE 20090433A1
- Authority
- PE
- Peru
- Prior art keywords
- staurosporin
- benzoyl
- procedure
- preparation
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Abstract
SE REFIERE A UN PROCESO PARA PURIFICAR ESTAUROSPORINA QUE COMPRENDE: A) PROPORCIONAR UNA SUSPENSION DE ESTAUROSPORINA EN UN SOLVENTE DE ALCOHOL TAL COMO ETANOL; B) PONER EN CONTACTO LA SUSPENCION CON ACIDO METANSULFONICO; C) ADEMAS PONER EN CONTACTO LA SOLUCION CON TRIETIL-AMINA; D) AISLAR EL PRODUCTO; Y E) LAVAR EL PRODUCTO AISLADO CON EL SOLVENTE DE ALCOHOL. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION DE N-BENZOIL-ESTAUROSPORINA QUE COMPRENDE: A) HACER REACCIONAR ESTAUROSPORINA CON ANHIDRIDO BENZOICO PARA FORMAR UNA SOLUCION; B) SEMBRAR LA SOLUCION CON N-BENZOIL-ESTAUROSPORINA AMORFA; Y C) AISLAR EL PRODUCTO
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62534304P | 2004-11-05 | 2004-11-05 | |
US64213105P | 2005-01-07 | 2005-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090433A1 true PE20090433A1 (es) | 2009-05-05 |
Family
ID=35501294
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012002519A PE20130377A1 (es) | 2004-11-05 | 2005-11-04 | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion |
PE2005001297A PE20060947A1 (es) | 2004-11-05 | 2005-11-04 | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion |
PE2009000199A PE20090433A1 (es) | 2004-11-05 | 2005-11-04 | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012002519A PE20130377A1 (es) | 2004-11-05 | 2005-11-04 | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion |
PE2005001297A PE20060947A1 (es) | 2004-11-05 | 2005-11-04 | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion |
Country Status (31)
Country | Link |
---|---|
US (2) | US8198435B2 (es) |
EP (3) | EP2955186A1 (es) |
JP (4) | JP5057986B2 (es) |
KR (3) | KR101289998B1 (es) |
CN (2) | CN102993213A (es) |
AR (1) | AR052322A1 (es) |
AU (2) | AU2005300693B2 (es) |
BR (1) | BRPI0517689A (es) |
CA (1) | CA2584911C (es) |
CY (1) | CY1113059T1 (es) |
DK (1) | DK1812448T3 (es) |
EC (1) | ECSP12007431A (es) |
ES (1) | ES2388142T3 (es) |
GT (1) | GT200500311A (es) |
HK (2) | HK1108881A1 (es) |
HR (1) | HRP20120652T1 (es) |
IL (3) | IL182691A (es) |
JO (1) | JO2897B1 (es) |
MA (1) | MA29033B1 (es) |
MX (2) | MX2007005429A (es) |
MY (2) | MY154878A (es) |
NO (2) | NO338960B1 (es) |
NZ (3) | NZ599033A (es) |
PE (3) | PE20130377A1 (es) |
PL (1) | PL1812448T3 (es) |
PT (1) | PT1812448E (es) |
RU (2) | RU2394038C2 (es) |
SI (1) | SI1812448T1 (es) |
TN (1) | TNSN07165A1 (es) |
TW (4) | TWI433852B (es) |
WO (1) | WO2006048296A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101516339B (zh) * | 2006-08-16 | 2012-06-13 | 诺瓦提斯公司 | 制备高度结晶的治疗化合物的固体分散体的方法 |
EP2327706A1 (en) | 2009-11-30 | 2011-06-01 | Novartis AG | Polymorphous forms III and IV of N-benzoyl-staurosporine |
KR20160008267A (ko) | 2014-07-14 | 2016-01-22 | 주식회사 윈스 | 네트워크 기반 영상감시체계에서의 사용자 행위 분석 시스템 |
WO2018165071A1 (en) * | 2017-03-06 | 2018-09-13 | Teva Pharmaceutical Works Ltd. | Solid state forms of midostaurin |
WO2019215759A1 (en) * | 2018-05-09 | 2019-11-14 | Alaparthi Lakshmi Prasad | An improved process for preparation of midostaurin |
IT201900004729A1 (it) | 2019-03-29 | 2020-09-29 | Procos Spa | Processo per la preparazione di midostaurina ad elevato grado di purezza |
WO2020261293A1 (en) * | 2019-06-24 | 2020-12-30 | Dr. Reddy's Laboratories Limited | Process for preparation of midostaurin |
IT201900014346A1 (it) * | 2019-08-08 | 2021-02-08 | Procos Spa | Processo per la preparazione di midostaurina amorfa con un basso contenuto di solvente organico residuo |
IT202000004291A1 (it) | 2020-03-02 | 2021-09-02 | Indena Spa | Processo per la purificazione di alcaloidi indolo carbazolici |
CN111393454A (zh) * | 2020-05-07 | 2020-07-10 | 奥锐特药业(天津)有限公司 | 米哚妥林的新晶型及其制备方法 |
CN115124551B (zh) * | 2021-03-24 | 2024-04-30 | 奥锐特药业(天津)有限公司 | 一种高纯度米哚妥林的制备方法 |
WO2023205504A1 (en) * | 2022-04-22 | 2023-10-26 | Rutgers, The State University Of New Jersey | Formulations and methods for treating epidermolysis bullosa simplex and related conditions |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5373501A (en) * | 1976-12-11 | 1978-06-30 | Kitasato Inst | Novel antibiotics amm2282 and process for preparing same |
JPS60185719A (ja) | 1984-03-06 | 1985-09-21 | Ajinomoto Co Inc | 抗腫瘍剤 |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
IL86632A0 (en) | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
US5073633A (en) * | 1989-03-23 | 1991-12-17 | Bristol-Myers Company | BMY-41950 antitumor antibiotic |
US5096330A (en) * | 1990-06-21 | 1992-03-17 | M-B-W Inc. | Pitch control mechanism for a surface finishing machine |
JPH05247055A (ja) * | 1992-03-03 | 1993-09-24 | Meiji Seika Kaisha Ltd | スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤 |
JPH05247955A (ja) | 1992-03-06 | 1993-09-24 | Taisei Corp | 擁壁の施工方法 |
DE69326388T2 (de) | 1992-06-22 | 1999-12-30 | Kyowa Hakko Kogyo Kk | Verfahren zur Herstellung von Staurosporin-Derivaten |
WO1995032975A1 (en) * | 1994-06-01 | 1995-12-07 | Ciba-Geigy Ag | Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents |
JP4070810B2 (ja) | 1995-12-11 | 2008-04-02 | セファロン・インコーポレイテッド | タンパク質キナーゼcの阻害剤としての縮合イソインドロン |
JP4625603B2 (ja) * | 1999-08-30 | 2011-02-02 | ポリファー アーゲー | テンプレートを固定したβヘアピンループ類似物の合成 |
US20040077232A1 (en) | 2001-03-26 | 2004-04-22 | Andreas Ebner | Pharmaceutical compositions |
KR100407758B1 (ko) * | 2001-08-27 | 2003-12-01 | 씨제이 주식회사 | 스타틴의 제조에 있어서 락톤화 방법 |
US7608420B2 (en) | 2003-04-22 | 2009-10-27 | Lonza Ag | Process for the recovery of staurosporine from a fermentation broth |
-
2005
- 2005-10-26 JO JO2005162A patent/JO2897B1/en active
- 2005-10-28 GT GT200500311A patent/GT200500311A/es unknown
- 2005-10-28 MY MYPI20091911A patent/MY154878A/en unknown
- 2005-10-28 MY MYPI20055091A patent/MY147404A/en unknown
- 2005-11-03 NZ NZ599033A patent/NZ599033A/xx not_active IP Right Cessation
- 2005-11-03 PT PT05803350T patent/PT1812448E/pt unknown
- 2005-11-03 US US11/718,029 patent/US8198435B2/en active Active
- 2005-11-03 ES ES05803350T patent/ES2388142T3/es active Active
- 2005-11-03 PL PL05803350T patent/PL1812448T3/pl unknown
- 2005-11-03 RU RU2007120695/04A patent/RU2394038C2/ru active
- 2005-11-03 JP JP2007539535A patent/JP5057986B2/ja active Active
- 2005-11-03 CN CN2012104320940A patent/CN102993213A/zh active Pending
- 2005-11-03 MX MX2007005429A patent/MX2007005429A/es active IP Right Grant
- 2005-11-03 CN CN2012101018747A patent/CN102627658A/zh active Pending
- 2005-11-03 CA CA2584911A patent/CA2584911C/en active Active
- 2005-11-03 KR KR1020127022584A patent/KR101289998B1/ko active IP Right Grant
- 2005-11-03 DK DK05803350.7T patent/DK1812448T3/da active
- 2005-11-03 BR BRPI0517689-1A patent/BRPI0517689A/pt not_active IP Right Cessation
- 2005-11-03 EP EP15171908.5A patent/EP2955186A1/en not_active Withdrawn
- 2005-11-03 AU AU2005300693A patent/AU2005300693B2/en active Active
- 2005-11-03 NZ NZ588025A patent/NZ588025A/en not_active IP Right Cessation
- 2005-11-03 EP EP05803350A patent/EP1812448B1/en active Active
- 2005-11-03 SI SI200531555T patent/SI1812448T1/sl unknown
- 2005-11-03 EP EP10173464.8A patent/EP2272850B1/en active Active
- 2005-11-03 WO PCT/EP2005/011789 patent/WO2006048296A1/en active Application Filing
- 2005-11-03 NZ NZ554653A patent/NZ554653A/en not_active IP Right Cessation
- 2005-11-03 KR KR1020127022582A patent/KR101265850B1/ko active IP Right Grant
- 2005-11-03 MX MX2011007303A patent/MX346525B/es unknown
- 2005-11-03 KR KR1020077010191A patent/KR101333851B1/ko active IP Right Grant
- 2005-11-04 AR ARP050104637A patent/AR052322A1/es not_active Application Discontinuation
- 2005-11-04 PE PE2012002519A patent/PE20130377A1/es not_active Application Discontinuation
- 2005-11-04 PE PE2005001297A patent/PE20060947A1/es not_active Application Discontinuation
- 2005-11-04 TW TW094138677A patent/TWI433852B/zh not_active IP Right Cessation
- 2005-11-04 PE PE2009000199A patent/PE20090433A1/es not_active Application Discontinuation
- 2005-11-04 TW TW101122880A patent/TWI530500B/zh not_active IP Right Cessation
- 2005-11-04 TW TW101122882A patent/TWI455941B/zh not_active IP Right Cessation
- 2005-11-04 TW TW103130302A patent/TWI530501B/zh not_active IP Right Cessation
-
2007
- 2007-04-19 IL IL182691A patent/IL182691A/en active IP Right Grant
- 2007-05-02 NO NO20072290A patent/NO338960B1/no unknown
- 2007-05-04 TN TNP2007000165A patent/TNSN07165A1/fr unknown
- 2007-05-22 MA MA29924A patent/MA29033B1/fr unknown
- 2007-12-19 HK HK07113889.0A patent/HK1108881A1/xx unknown
- 2007-12-19 HK HK15112508.3A patent/HK1211587A1/xx unknown
-
2009
- 2009-10-13 RU RU2009137788/04A patent/RU2467012C2/ru active
- 2009-12-07 AU AU2009245817A patent/AU2009245817B2/en active Active
-
2010
- 2010-08-19 IL IL207702A patent/IL207702A/en active IP Right Grant
-
2012
- 2012-01-16 IL IL217571A patent/IL217571A/en active IP Right Grant
- 2012-03-12 EC ECSP12007431 patent/ECSP12007431A/es unknown
- 2012-05-11 JP JP2012109447A patent/JP5701246B2/ja active Active
- 2012-05-15 US US13/472,130 patent/US8710216B2/en active Active
- 2012-08-10 HR HRP20120652TT patent/HRP20120652T1/hr unknown
- 2012-08-21 CY CY20121100747T patent/CY1113059T1/el unknown
-
2015
- 2015-01-09 JP JP2015003634A patent/JP2015063569A/ja not_active Withdrawn
-
2016
- 2016-07-12 NO NO20161152A patent/NO340404B1/no unknown
-
2017
- 2017-01-13 JP JP2017004320A patent/JP2017061578A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090433A1 (es) | Forma cristalina (ii) de n-benzoil-estaurosporina y procedimiento para su preparacion | |
AR062148A1 (es) | Proceso quimico para la preparacion de intermediarios | |
MA29781B1 (fr) | Procede regioselectif de preparation de benzimidazole thiophenes | |
ECSP055910A (es) | Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
WO2010067374A3 (en) | Polymorphs of dasatinib | |
WO2008075376A8 (en) | Polymorphic forms of bortezomib and process for their preparation | |
ATE485261T1 (de) | Salicylsäurederivate | |
CL2012000560A1 (es) | Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08). | |
CL2009001414A1 (es) | Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina. | |
WO2012031045A3 (en) | Phosphonate ester derivatives and methods of synthesis thereof | |
EP2407444A3 (en) | Process for the preparation of dodecanedioic acid | |
AR051341A1 (es) | Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina | |
TW200716555A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
DE602006014001D1 (de) | Herstellung von 2-aminothiazol-5-carbonsäurederivaten | |
WO2009116072A3 (en) | Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates | |
MX2008000011A (es) | Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos. | |
NZ598278A (en) | Process for preparing biphenyl imidazole compounds | |
PL2010538T3 (pl) | Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego | |
PE20090534A1 (es) | Polimorfos de s,s-dioxido del acido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f] [1,2]tiazepin-11-il)amino]heptanoico y metodos para su preparacion y uso | |
SG162815A1 (en) | Process for preparing benzimidazole compounds | |
EP2145962A3 (en) | Process for the manufacture of eptifibatide | |
Rajakumar et al. | Synthesis and antimicrobial activity of some novel dicationic sulphonophanes | |
WO2010064785A3 (en) | Method for selectively crystallizing a z isomer of iopromide | |
WO2012052939A3 (en) | Preparation of bicyclo[2.2.2]octan-2-one compounds | |
CA2707173A1 (en) | Crystallization of iodixanol in isopropanol and methanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |